Joint Study on Angiogenesis and Growth Factor Responses
Joint Study on Angiogenesis and Growth Factor Responses
批准号:
06044179
负责人:
KUWANO Michihiko
金额:
$5.25万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
M.Kuwano, M.Ono, Y.Sato和K.Kohno与K.Miyazono, D.Rifkin和h . f.合作完成了血管生成和生长因子反应的联合研究。我们得到的结果如下所述。我们最近建立了体外血管生成模型,将I型胶原凝胶上的血管内皮细胞内腔与外腔中其他类型的细胞共培养。体外培养人软骨细胞可抑制EGF/TGFalpha依赖性血管内皮细胞的管状形成。这种由软骨细胞诱导的管形成抑制被抗TGF β抗体部分消除,提示TGF β部分参与了人软骨细胞依赖性血管的形成。H-ras癌基因的引入降低了小鼠Balb/3T3细胞中EGF与所有表面EGF受体的结合活性。在H-ras转染中,EGF受体基因表达被破坏,但V-myc的共同引入使EGF受体恢复到正常水平。引入编码转录失活产物的显性阴性c-jun突变体,抑制了H-ras依赖性AP-1 (Jun/Fos)的诱导,并恢复了H-ras癌基因对EGF结合的下调。在包括炎症在内的各种病理条件下都会诱导氧自由基。过氧化氢(H_2O_2)诱导人微血管内皮细胞形成管状结构,同时给予NFkB反义序列抑制H_2O_2依赖性管状结构的形成,在抗il - 8抗体存在时几乎完全消除。氧化刺激后血管内皮细胞的管状形态形成似乎与NFkB和IL8.4有关。临床上使用的依格列定在10^< -6> ~ 10^<-4>M范围内作为抗胃溃疡药物,特异性地抑制了血管内皮细胞的细胞增殖和管状形成。口服伊索格拉定30 ~ 120mg /kg/天抑制人肿瘤细胞在小鼠体内的生长和血管生成。少
英文摘要
M.Kuwano, M.Ono, Y.Sato and K.Kohno have done the joint study on angiogenesis and growth factor responses in collaboration with K.Miyazono, D.Rifkin and H-f.Kung, and we obtained results as described below.1. We have recently established angiogenesis model in vitro in wihch vascular endothelial cells on type I collagen gel in an inner chamber are co-cultured with other types of cells in an outer chamber. EGF/TGFalpha dependent tube formation of vascular endothelial cells was inhibited when human chondrocytes were co-cultured in the outer chamger. This chondrocype-induced inhibition of tube fomation was partly abrogated by administraion of anti-TGF beta antibody, suggesting that TGF beta is partly involved in the human chondrocyte-dependent avascularily.2. Introduction of H-ras oncogene decreased the EGF binding activity to all surface EGF receptor in mouse Balb/3T3 cells. EGF receptor gene expression was abrogated in the H-ras transfectants, but co-introduction of V-myc restored the EG … More F receptor to normal levels.Introduction of dominant-negative c-jun mutant encoding a transcriptionally inactive product inhibited the H-ras dependent AP-1 (Jun/Fos) induction, and also restored down-regulation of EGF binding by H-ras oncogene.3. Oxygen radicals are induced under various pathological conditions including inflamation. Treatment with hydrogen peroxide (H_2O_2) of human microvascular endothelial cells induced development of tube-like structres, and co-administration of antisense sequence of NFkB inhibited the H_2O_2 dependent tubular morphogenesis was almost completely abrogated when anti-IL8 antibody was present. Tubular morphogenesis of vascular endothelial cells after the oxidative stimuli appeared to be associated with NFkB and IL8.4. Irogladine used clinically as an anti-gasTriculcer agent at 10 ^<-6> to 10^<-4>M inhibited specifically cell proliferation and tube formation of vascular endothelial cells. Oral administration of irsogladine at 30 to 120 mg/kg/day inhibited both tumor growth and tumor angiogenesis when human tumor cells were transplanted in mice. Less
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
M.Ono: "Inhibition of tumor growth and neovascularization by an anti-gastriculcer agent,irsogladine." Cancer Res.(in press). (1996)
M.Ono:“抗胃溃疡药物伊索拉定抑制肿瘤生长和新血管形成。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Abe: "Expression of 72kDa type IV collagenase and invasion activity of human glioma cells." Clinical & Experiment.Metastasis. 12. 296-304 (1994)
T.Abe:“72kDa IV 型胶原酶的表达和人胶质瘤细胞的侵袭活性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Ito: "Expression of tissue-type plasminogen activator and Tts inhibitor couples with development of Capillary network by human microvascular endothelial cells on matrigel." J.Cell.Physiol.162. 213-224 (1994)
K.Ito:“组织型纤溶酶原激活剂和 Tts 抑制剂的表达与基质胶上人微血管内皮细胞毛细血管网络的发育相结合。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
和泉弘人: "サイトカインを用いた癌治療" 医薬ジャーナル社, 17 (1994)
Hiroto Izumi:“使用细胞因子进行癌症治疗”Iyaku Journalsha,17(1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Okimoto: "Regulation of epidermal growth factor receptor by activated H-ras and v-myc oncogenes in mouse balb/3T3 cells: possible roles of AP-1." Oncogene. 12(in press). (1996)
T.Okimoto:“小鼠 balb/3T3 细胞中激活的 H-ras 和 v-myc 癌基因对表皮生长因子受体的调节:AP-1 的可能作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Novel approach to overcome malignant cancer by targeting Y-box binding protein-1(YB-1)
-
批准号:24650646
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:KUWANO Michihiko
-
依托单位:
Human Y-box binding protein1(YB-1) : Mechanism for the nuclear translocation and its role of tumor growth and drug resistance-
-
批准号:19590324
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:KUWANO Michihiko
-
依托单位:
ABC Transporters in Cancer and Other Diseases
-
批准号:11694286
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$5.12万
-
财政年份:1999
-
负责人:KUWANO Michihiko
-
依托单位:
Human model system for angiogenesis and molecular mechanisms on function of growth factors involving in the angiogenesis
-
批准号:04454175
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1992
-
负责人:KUWANO Michihiko
-
依托单位:
Joint study on human genomic analysis of drug resistance
-
批准号:03044118
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.12万
-
财政年份:1991
-
负责人:KUWANO Michihiko
-
依托单位:
Oligosaccharide Analysis of the Low Density Lipoprotein Receptors in Golgi Mutants
-
批准号:63044114
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.14万
-
财政年份:1989
-
负责人:KUWANO Michihiko
-
依托单位:
Classification of human hypercholesterolemia by using somatic cell mutants with altered response to low density lipoprotein.
-
批准号:62870012
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$8.96万
-
财政年份:1987
-
负责人:KUWANO Michihiko
-
依托单位:
Altered structure of LDL receptor and cholesterol metabolic defects.
-
批准号:62480134
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1987
-
负责人:KUWANO Michihiko
-
依托单位:
Somatic Cell Genetic Mutants with Altered Cholesterol Metabolism and Altered Endocytosis of Low Density Lipoprotein
-
批准号:60480142
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1985
-
负责人:KUWANO Michihiko
-
依托单位:
海外基金